General Updates

Bacterial Mitigation in Platelets

Summary Statement Vitalant Disaster Preparedness Plan 1.25.2021

• Summary Statement Vitalant Disaster Preparedness Plan 1-25-2021.pdf

Summary Statement Vitalant Quality Plan 1.25.2021

• Summary Statement Vitalant Quality Plan 1.25.2021.pdf

TRALI Mitigation Policy

• TRALI Mitigation Policy (PDF)

Red Cell Contamination in Platelets and Apheresis Granulocytes

• Red Cell Contamination in Platelets and Apheresis Granulocytes (PDF)

Blood Component Quality Control Program for RBC and Apheresis Platelets

• Blood Component Quality Control Program for RBC and Apheresis Platelets (PDF)

Blood Use Optimization

• Choosing Wisely Campaign: AABB List of Recommendations to Optimize Blood Use (Posted with permission from AABB.)

Bacterial Detection QC for Platelets

• Bacterial Detection Quality Control for Platelets (PDF)

Babesia Microti Testing for Blood Collected in High-Risk Endemic States

• Babesia microti  Testing for Blood Collected in High-risk Endemic States (PDF)

Suspected Platelet Refractory State

• Evaluation of the Patient with Suspected Platelet Refractory State (PDF) (Physician's Guide)

Compliance Alert, January 2013: Important Information for All Laboratories

• Compliance Alert, January 2013: Important Information for All Laboratories (PDF)

Rationale for Universal Leukoreduction (ULR)

• Rationale for Universal Leukoreduction (ULR) (PDF)

Reintroduction of Nonleukoreduced Blood Components

• Commentary on the safety of the reintroduction of nonleukoreduced blood components in hospitals that previously implemented universal leukoreduction (Transfusion, 2011)

NAT in Blood Screening Around the World

• NAT in Blood Screening Around the World by Frank Strobl, MD, PhD

Compliance Alert, March 2011: Important Information for All Transfusion Services

• Compliance Alert, March 2011: Important Information for All Transfusion Services (PDF)

Small Volume Transfusions in Neonates

• Small Volume Transfusions in Neonates: Red Cells in Additive Solution are an Acceptable Choice (PDF) by Leon Su, MD

Coagulation Updates

• Anticoagulation Monitoring
• Platelet Aggregation Testing (PDF)

Transfusion Medicine Updates

Transfusion Medicine Updates published from February 1992 to the present that are relevant to the Coagulation Laboratory.
2011 Issue #1, Dabigatran, a New Oral Anticoagulant & Its Role in Clinical Practice (PDF), Irina Chibisov, M.D., Andrea Cortese Hassett, Ph.D.
2005 Issue #4, Aspirin Resistance (PDF), Zella Zeigler, M.D.
2004 Issue #3, Quantitative D-dimer: Ruling out Venous Thrombosis (PDF), Andrea Cortese Hassett, Ph.D.
2002 Issue #5, Platelet Function Testing (PDF), Andrea Cortese Hassett, Ph.D.
2001 January, Activated Protein C Resistance (PDF), Andrea Cortese-Hassett, Ph.D., Franklin A. Bontempo, M.D.
2000 February, D-dimer Testing and Acute Venous Thromboembolism, (PDF) Andrea Cortese-Hassett, Ph.D.
2000 July, Closure Time Platelet Function Screening (PDF), Andrea Cortese-Hassett, Ph.D.
1996 February, Heparin Monitoring (PDF), Andrea Cortese-Hassett, Ph.D.
1996 June, Low Molecular Weight Heparin (PDF), Franklin A. Bontempo, M.D., Andrea Cortese-Hassett, Ph.D.
1995 June, The INR (International Normalized Ratio) FOR Monitoring Oral Anticoagulant Therapy (PDF), Andrea Cortese-Hassett, Ph.D., Frank A. Bontempo, M.D.
1995 August, The Factor V Leiden Mutation (PDF), Franklin A. Bontempo, M.D., Andrea Cortese-Hassett, Ph.D.
1994 April, Use and Misuse of the Bleeding Time (PDF), Franklin A. Bontempo, M.D.
1994 October, von Willebrand Disease (PDF), Margaret V. Ragni, M.D., M.P.H.